These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Brazilian Consensus on second-generation antipsychotics and metabolic disorders]. Elkis H; Gama C; Suplicy H; Tambascia M; Bressan R; Lyra R; Cavalcante S; Minicucci W Braz J Psychiatry; 2008 Mar; 30(1):77-85. PubMed ID: 18373022 [TBL] [Abstract][Full Text] [Related]
24. Schizophrenia and obesity: impact of antipsychotic medications. Wirshing DA J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381 [TBL] [Abstract][Full Text] [Related]
25. Medication-induced weight gain and dyslipidemia in patients with schizophrenia. Fenton WS; Chavez MR Am J Psychiatry; 2006 Oct; 163(10):1697-704; quiz 1858-9. PubMed ID: 17012676 [No Abstract] [Full Text] [Related]
26. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. Newcomer JW J Clin Psychiatry; 2007; 68 Suppl 1():20-7. PubMed ID: 17286524 [TBL] [Abstract][Full Text] [Related]
30. Weight gain and metabolic syndrome among young patients on antipsychotic medication: what do we know and where do we go? Eapen V; John G Australas Psychiatry; 2011 Jun; 19(3):232-5. PubMed ID: 21682621 [TBL] [Abstract][Full Text] [Related]
31. The adjunctive use of metformin to treat or prevent atypical antipsychotic-induced weight gain: a review. Khan AY; Macaluso M; McHale RJ; Dahmen MM; Girrens K; Ali F J Psychiatr Pract; 2010 Sep; 16(5):289-96. PubMed ID: 20859106 [TBL] [Abstract][Full Text] [Related]
32. [The metabolic syndrome and antipsychotics in children and adolescents]. Dori N; Green T Harefuah; 2011 Oct; 150(10):791-6, 814, 813. PubMed ID: 22111125 [TBL] [Abstract][Full Text] [Related]
33. [Antipsychotic prescription assessment in general practice: metabolic effects]. Gignoux-Froment F; de Montleau F; Saravane D; Verret C Encephale; 2012 Dec; 38(6):453-9. PubMed ID: 23200610 [TBL] [Abstract][Full Text] [Related]
35. Antipsychotic induced weight gain in schizophrenia:mechanisms and management. Rege S Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255 [TBL] [Abstract][Full Text] [Related]
36. Metabolic syndrome with different antipsychotics: a multicentre cross-sectional study. Cerit C; Vural M; Bos Gelmez SÜ; Ozten E; Aker AT; Yıldız M Psychopharmacol Bull; 2010; 43(4):22-36. PubMed ID: 21240150 [TBL] [Abstract][Full Text] [Related]
37. Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs. Hasnain M; Fredrickson SK; Vieweg WV J Psychopharmacol; 2011 Jun; 25(6):715-21. PubMed ID: 21169390 [TBL] [Abstract][Full Text] [Related]
38. When essential medications provoke new health problems: the metabolic effects of second-generation antipsychotics. Stein K J Am Diet Assoc; 2010 Jul; 110(7):992-1001. PubMed ID: 20630154 [No Abstract] [Full Text] [Related]
39. Association of weight gain and metabolic syndrome in patients taking clozapine: an 8-year cohort study. Bai YM; Lin CC; Chen JY; Chen TT; Su TP; Chou P J Clin Psychiatry; 2011 Jun; 72(6):751-6. PubMed ID: 21208584 [TBL] [Abstract][Full Text] [Related]